The Limited Times

Now you can see non-English news...

Four batches of two herpes simplex drugs containing carcinogenic impurities must be recalled

2022-04-28T13:11:00.023Z


The Department of Health today (28) agreed to a licensed drug wholesaler, Hin Wing Hong Limited (Hsien Wing Hong), to take precautionary measures to recall two prescription drugs for the treatment of herpes simplex from the market, involving four batches.


The Department of Health today (28) agreed to a licensed drug wholesaler, Hin Wing Hong Limited (Hsien Wing Hong), to take precautionary measures to recall two prescription drugs for the treatment of herpes simplex from the market, involving four batches. Cancer-causing impurities.


The Department of Health was notified by Hin Wing Hing that two prescription drugs for the treatment of herpes simplex will be recalled from the market.

(Photo by the Department of Health)

The Department of Health said it was notified by Hin Wing Hong today that the overseas manufacturer of the drug is voluntarily recalling the batches of the affected batches as they contain higher than acceptable levels of the impurity N-nitrosodimethylamine (NDMA). product.

Based on laboratory test results, NDMA is classified as potentially carcinogenic to humans.

As a precautionary measure, Hin Wing Hong voluntarily recalls affected products from the market.

The above products are prescription medications used to treat herpes simplex.

According to Hin Wing Hong, the affected products were imported into Hong Kong and supplied to local doctors, pharmacies and clinics of the Department of Health.

Hin Wing Hong has set up a hotline (2541 5731) to answer related enquiries.

A spokesman for the Department of Health said that it has not received any reports of adverse reactions involving the product so far, and will closely monitor the recall. Patients who are taking the product should not stop taking the drug on their own, but should consult their medical staff as soon as possible. appropriate arrangements.

The Department of Health recalls all Salonpas topical anti-inflammatory and analgesic patches in two-piece Japan is also recalling the cancer drug Tepadina 100 from the Department of Health. It was once supplied to the HA and private hospitals. Department of Health recalls minocycline hydrochloride injection product containing a piece of glass shards Department of Health recalls bladder cancer drug "Mitomycin-C powder for injection" due to lack of sterility

Source: hk1

All news articles on 2022-04-28

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.